Kymera Therapeutics chief legal officer Adams disposes of $744k in KYMR stock

Kymera Therapeutics' Chief Legal Officer, Brian Adams, sold $744,297 worth of company stock on September 4, 2026. The transactions were to satisfy tax obligations related to the vesting of restricted stock units. Mr. Adams sold 1,209 shares at an average price of $115.55, 3,025 shares at $116.81, and 2,137 shares at $117.57, resulting in an overall loss of $251,287.

Despite the sale, Adams still holds 50,254 shares of Kymera Therapeutics common stock. The company's stock, currently trading around $117.39, has seen a 178% return over the past year and a 36% increase in the last six months. However, some analysts believe the stock may be overvalued at its current level.